Poseidon is a start-up biotechnology company which seeks to engineer and develop novel protein binding partners for specific and strategically targeted biological molecules. Particular focus is given to the intracellular space, where current biologics tend to fall short. Engineered protein interactions are developed with the aim of altering or inhibiting the endogenous functional processes of the targeted molecule.
Our engineered scaffold is a unique monomeric protein domain with bi-specific interaction capabilities. It also has the ability to be developed as a targeted delivery vehicle for potent drug conjugates.